Bottom line
Is ARTMX a good fund? The bottom line
ARTMX is the Investor share class of Artisan Mid Cap Fund, a managed mid-cap mutual fund from Artisan Partners.
Its expense ratio is 1.21% — about $121 a year on every $10,000 invested, more expensive than 78% of mid-cap funds we track.
It returned +14.8% over one year, +2.1% a year over five years, +10.8% a year over ten (as of Dec 31, 2025, per its prospectus).
With $3.2 billion in net assets and 64 holdings, its largest position is Argenx SE (4.9%) and the top 10 make up 34.5% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (1.21%)
- 5-year return in the bottom quarter of its category
Updated Nov 19, 2026
What ARTMX invests in
The Fund seeks long-term capital growth.
The Funds investment team employs a fundamental investment process to construct a diversified portfolio of US mid-cap growth companies. The team seeks to invest in companies that it believes possess franchise characteristics, are benefiting from an accelerating profit cycle and are trading at a discount to its estimate of private market value. The Funds investment process focuses on two distinct elementssecurity selection and capital allocation. The team overlays its investment process with sustainability considerations and broad knowledge of the global economy. Security Selection The team seeks to identify companies that have franchise characteristics (e.g., low cost production capability, possession of a proprietary asset, dominant market share or a defensible brand name), are benefiting from an accelerating profit cycle and are trading at a discount to the teams estimate of private…
From the fund's prospectus (filed Aug 31, 2026).
ARTMX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| ARTMX | +14.8% | +2.1% | +10.8% |
| Mid-Cap median | +7.9% | +8.1% | +9.9% |
Source: Fund prospectus, as of Dec 31, 2025
What ARTMX costs
On a $10,000 investment, ARTMX's 1.21% expense ratio costs about $121 a year. The prospectus estimates $1,466 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.
ARTMX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Argenx SE | 4.93% |
| 2 | Ascendis Pharma A/S | 4.51% |
| 3 | Comfort Systems USA, Inc. | 3.89% |
| 4 | West Pharmaceutical Services, Inc. | 3.78% |
| 5 | Lattice Semiconductor Corp. | 3.37% |
| 6 | RBC Bearings, Inc. | 3.03% |
| 7 | Twist Bioscience Corp. | 2.88% |
| 8 | Woodward, Inc. | 2.82% |
| 9 | BlackRock Liquidity Funds Treasury Trust Fund | 2.71% |
| 10 | Spotify Technology SA | 2.58% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 34.5% of the fund. See all top 25 holdings and asset mix →